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TAR DNA-binding protein (TDP-43) is a highly conserved
and essential DNA- and RNA-binding protein that controls
gene expression through RNA processing, in particular, regula-
tion of splicing. Intracellular aggregation of TDP-43 is a hall-
mark of amyotrophic lateral sclerosis and ubiquitin-positive
frontotemporal lobar degeneration. This TDP-43 pathology is
also present in other types of neurodegeneration including Alz-
heimer’s disease. We report here that TDP-43 is a substrate of
MEK, a central kinase in the MAPK/ERK signaling pathway.
TDP-43 dual phosphorylation by MEK, at threonine 153 and
tyrosine 155 (p-T153/Y155), was dramatically increased by the
heat shock response (HSR) in human cells. HSR promotes cell
survival under proteotoxic conditions by maintaining protein
homeostasis and preventing protein misfolding. MEK is acti-
vated by HSR and contributes to the regulation of proteome
stability. Phosphorylated TDP-43 was not associated with
TDP-43 aggregation, and p-T153/Y155 remained soluble
under conditions that promote protein misfolding. We found
that active MEK significantly alters TDP-43-regulated splic-
ing and that phosphomimetic substitutions at these two res-
idues reduce binding to GU-rich RNA. Cellular imaging using
a phospho-specific p-T153/Y155 antibody showed that phos-
phorylated TDP-43 was specifically recruited to the nucleoli,
suggesting that p-T153/Y155 regulates a previously unappre-
ciated function of TDP-43 in the processing of nucleolar-
associated RNA. These findings highlight a new mechanism
that regulates TDP-43 function and homeostasis through
phosphorylation and, therefore, may contribute to the devel-
opment of strategies to prevent TDP-43 aggregation and to
uncover previously unexplored roles of TDP-43 in cell
metabolism.
In recent years the role of RNA-binding proteins in neurode-
generative disorders, particularly amytrophic lateral sclerosis
(ALS) and frontotemporal lobar degeneration (FTLD)5 has
become the focus of intense research. The TAR DNA-binding
protein (TDP-43) forms cytoplasmic aggregates in almost all
ALS and 50% of FTLD cases (1, 2). TDP-43 pathology is
observed in other neurological disorders including Alzheimer’s
disease (3, 4). The direct role TDP-43 plays in disease is under-
scored by 40 ALS/FTLD patient-derived autosomal domi-
nant missense mutations in the TDP-43 gene (TARDBP) (5).
TDP-43 inclusions coincide with a dramatic reduction of the
normal nuclear TDP-43 detection (2), implying a loss of
function upon aggregate accumulation. The link between
neurodegeneration and TDP-43 function has not been
clearly established and the contribution of TDP-43 aggrega-
tion to pathogenesis is poorly understood.
TDP-43 is a highly conserved heterogeneous nuclear ribonu-
cleoprotein (hnRNP) with two canonical RNA recognition
motifs (RRMs) of which RRM1 is necessary and sufficient to
bind RNA. A low complexity sequence, or prion-like domain at
the C terminusmediates protein interactions required for RNA
processing (6, 7) and is the main driver of protein aggregation
(8). AlthoughTDP-43 shuttles between nucleus and cytoplasm,
it is predominantly nuclear (9). In the nucleus, TDP-43 shows a
diffuse pattern and recruitment to Cajal bodies and gems (10).
Under specific cellular stress conditions, such as oxidative
stress, TDP-43 localizes to cytoplasmic stress granules (11),
whichmay contribute to pathological aggregate formation (12).
TDP-43 is essential for development and survival in animal
models and cultured cells (13–17). In human cells and mouse
brain, TDP-43 binds thousands of transcripts with a strong
preference for GU-rich sequences and regulates600 protein-
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coding genes. TDP-43 controls these genes predominantly
through splicing regulation (18–20). Although TDP-43 partic-
ipates in different mechanisms of RNA processing and RNA
transport, the regulation of splicing is its best-characterized
function (20, 21). In addition, recent findings show thatTDP-43
plays a more global role in gene regulation as an inhibitor of
cryptic exon inclusion (22).
Despite evidence that TDP-43 controls a large number of
genes and is dynamically distributed in cells, the cellular stimuli
and factors that regulate TDP-43 function through posttrans-
lational modifications are still mostly unknown.We character-
ized new TDP-43 phosphorylation sites found in non-patho-
logical settings and sought to determine the mechanisms that
control them. Our findings show that activation of the cellular
heat shock response (HSR) dramatically increases TDP-43
phosphorylationatThr-153andTyr-155throughtheMAPK/ERK
kinase MEK, in the absence of increased TDP-43 aggregation or
protein clearance. IncreasedThr-153/Tyr-155phosphorylation in
the presence of activeMEK and phosphomimetic substitutions at
Thr-153/Tyr-155 show decreased splicing regulatory function.
Moreover, phosphomimetic substitutions at Thr-153/Tyr-
155 decrease RNA binding affinity, suggesting that phosphory-
lation at these sites modulates TDP-43 activity.
Results
The Heat Shock Response Controls TDP-43 Phosphorylation
in RRM1—TDP-43 phosphorylation at threonine 153 and tyro-
sine 155, located in RRM1 (Fig. 1, A and B), was identified by
large scale phosphoproteome mass spectrometry analysis of
human HeLa cells (23). These modifications were determined
under non-pathological conditions. To characterize these pre-
viously unexplored phosphorylation sites, we developed a novel
phospho-specific polyclonal antibody, p-T153/Y155-TDP-43,
to recognize dual TDP-43 phosphorylation at Thr-153/Tyr-
155. The basal levels of the protein recognized by p-T153/
Y155-TDP-43 were almost undetectable by immunoblotting in
different human cell lines including SH-SY5Y human neuro-
blastoma cells (Fig. 1,C andD, supplemental Fig. S1). However,
we found that heat shock dramatically up-regulated the
p-T153/Y155-TDP-43-associated signal. No significant increase
was observed under conditions of oxidative stress, DNA dam-
age stress, or transcription inhibition (Fig. 1C). Similar results
were obtained with heat shock stressed human HEK-293 (sup-
plemental Fig. S1) and HeLa cells (Fig. 2A). The levels of
p-T153/Y155-TDP-43-associated signal were undetectable in
control cell lysates with150 g of total protein (Fig. 1D, sup-
plemental Fig. S1). In contrast, this signal was observed in heat
shock-treated cell lysate starting from 20 g of total protein
(Fig. 1D, supplemental Fig. S1). We confirmed antibody speci-
ficity for TDP-43 phosphorylation at Thr-153/Tyr-155 through
different analyses. The signal associated with p-T153/Y155-
TDP-43 following heat shock was significantly reduced upon
TDP-43 knockdown (Fig. 2A). Incubation of the antibody with
a TDP-43 peptide (amino acids 148–161) phosphorylated at
Thr-153 and Tyr-155 resulted in a loss of the p-T153/Y155-
TDP-43-associated signal, whereas the non-phosphorylated
control peptide had no effect (Fig. 2B). Furthermore, phospha-
tase treatment of lysate from heat-shocked cells decreased the
levels of the p-T153/Y155-TDP-43-associated signal compared
with control (Fig. 2C). To further characterize the specificity of
our new antibody for dual phosphorylation at Thr-153 andTyr-
155, we determined p-T153/Y155-TDP-43 activity toward sin-
gle phosphorylation at Thr-153 or Tyr-155. Immunoblotting
competition assays were carried out using peptides phosphor-
ylated at single amino acid residues Thr-153 or Tyr-155 (sup-
plemental Fig. S2, A and B). The peptide phosphorylated at
Thr-153 (Thr(P)-153) was unable to block recognition of the
p-T153/Y155-TDP-43-associated band. Similar high concen-
trations of the Tyr-155 phosphorylated peptide (Tyr(P)-155,
0.1 g/ml) showed partial inhibition of p-T153/Y155-TDP-43
activity. However, blocking the antibody with decreasing con-
centrations of the Tyr(P)-155 peptide showed no significant
competing activity as compared with equal concentrations of
the p-T153/Y155 dual phosphorylated peptide (supplemental
Fig. S2B). Furthermore, we analyzed whether the heat shock-
associated signal could be detected by an antibody generated to
recognize single phosphorylation at Tyr-155 (p-Y155-TDP-
43). This antibody showed no detection of the p-T153/Y155-
TDP-43-associated signal under control or heat shock condi-
tions (supplemental Fig. S2C). Collectively, these results
strongly support the specificity of the newly developed p-T153/
Y155-TDP-43 antibody for dual TDP-43 phosphorylation at
Thr-153 andTyr-155, and show the regulation of TDP-43 post-
translational modification by the HSR.
To confirm our results and to determine whether phosphor-
ylation at Thr-153/Tyr-155 modifies cellular localization of
TDP-43, we characterized the p-T153/Y155-TDP-43 antibody
by indirect immunofluorescence analysis. In non-treated cells,
the p-T153/Y155-TDP-43-associated signal localized in the
nucleolar compartment as dense coil-like structures (Fig. 3).
This was observed in different human cell lines, including
HeLa, SH-SY5Y (Fig. 3, A and B), U2-OS, and HEK-293 cells
(not shown). We confirmed antibody specificity for TDP-43
phosphorylation at Thr-153/Tyr-155 in our immunofluores-
cence assays by RNAi-mediated knockdown of TDP-43 and
competition assays with the Thr-153 and Tyr-155 phosphory-
lated peptide (amino acids 148–161) as above. Detection of the
nucleolar signal was blocked in the presence of the phosphory-
lated peptide, whereas incubation of the antibodywith the non-
phosphorylated form of the peptide had no effect (supplemen-
tal Fig. S3A). Furthermore, knockdown of TDP-43 via shRNA
reduced levels of the nucleolar signal compared with control
treated cells (supplemental Fig. S3B). These results suggest that
p-T153/Y155 is associated with nucleolar localization of
TDP-43 under normal conditions. This is in agreement with
previous mass spectrometry detection of TDP-43 in the nucle-
olar domain of HeLa cells (24). The levels of total TDP-43
recruited to nucleoli appear to be considerably lower compared
with the rest of the nucleus, based on the detection of phospho-
independent TDP-43 (Fig. 3A). Confocal microscopy analyses
of HeLa and SH-SY5Y cells suggest that phosphorylated
TDP-43 is part of the dense fibrillar component (DFC) of nucle-
oli as we observed significant colocalization with fibrillarin, a
well established DFCmarker (Fig. 3B). Localization of p-T153/
Y155 in the nucleolus was maintained following heat shock.
Quantification of p-T153/Y155 levels throughout the cell
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showed an increase in relative fluorescence after heat shock of
50 and 40% in HeLa and HEK-293 cells, respectively (Fig. 3C,
supplemental Fig. S4). Further experiments are required to
determine whether the increase in phosphorylation during
HSR primarily derives from changes in the nucleolar compart-
ment, relative to the rest of the cell.
TDP-43 Phosphorylation Is Not Associated with Aggregation,
Stress Granules, or Protein Clearance—We analyzed TDP-43
aggregation following heat shock to determine whether
p-T153/Y155 was associated with changes in protein solubility,
and to compare p-T153/Y155 with the two previously deter-
mined TDP-43 phosphorylation sites Ser-403/404, Ser-409/
410, which are tightly linked to aggregation and pathology (25,
26). Heat shock significantly induced misfolding and accumu-
lation of total TDP-43 in the insoluble fraction following pro-
tein extraction from cellular lysate (CL) into RIPA (R) and urea
(U) soluble fractions. Immunoblot analysis showed a great
reduction of total TDP-43 in the RIPA soluble fraction and a
corresponding increase in the urea soluble sample after heat
shock (Fig. 4A). In contrast, p-T153/Y155 was present exclu-
sively in the RIPA soluble fraction. Recovery fromheat shock by
incubation at 37 °C reduced the levels of total TDP-43 in the
urea fraction, indicating clearance of misfolded TDP-43 and/or
chaperone-assisted refolding of the protein. At the same time,
FIGURE1.Heat shock inducesTDP-43phosphorylationatThr-153andTyr-155.A, schematic representationhighlightingTDP-43domains linked toprotein
activity and structure: nuclear localization sequence (NLS) at the N terminus, RRM 1 and 2, and the low complexity sequence at the C terminus. Threonine 153
and tyrosine 155 (red) are highlighted in the RRM1 insert. B, ribbon and surface representation of TDP-43 RRM1–2 fragment (amino acids 102–269) bound to a
UG-rich RNA molecule (gray) based on an NMR structure of the complex (36). Thr-153 and Tyr-155 are highlighted in red. C, immunoblots of SH-SY5Y cells
exposed to heat shock, 43 °C for 30 min; treated with sodium arsenite, 0.5 mM for 1 h (NaAsn); H2O2, 100 M for 5 h; hydroxyurea, 4 mM for 4 h (HU); and
actinomycin D, 5 g/ml for 3 h (Act D). D, immunoblots of increasing cell lysate derived from control and heat shock-treated SH-SY5Y cells. An antibody
recognizing total, phospho-independent TDP-43 was used as control. Tubulin and GAPDH were used as loading control.
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the levels of p-T153/Y155 greatly decreased during recovery.
These results are consistent with imaging analysis, which
showed no accumulation of p-T153/Y155 into visible aggre-
gates following heat shock (Fig. 3C). Even though total TDP-43
accumulated in the urea fraction following heat shock, we did
not observe accumulation of total TDP-43 into cytoplasmic
aggregates (Fig. 3C), suggesting that TDP-43 present in the urea
fraction after heat shock represents misfolded species that may
precede formation of larger, visible aggregates.
To determine whether phosphorylation of Thr-153 and Tyr-
155 is associated with pathological inclusions in disease condi-
tions, we analyzed p-T153/Y155 localization in FTLD cases. As
positive control for the presence of TDP-43 pathology, we used
an antibody recognizing phosphorylated Ser-409/410, which is
a well established marker of TDP-43 disease-associated inclu-
sions (25). Immunohistochemical analysis of frontotemporal
dementia brain sections showed no significant accumulation of
p-T153/Y155 in aggregates (supplemental Fig. S5). These initial
observations suggest that, unlike previously identified phos-
phorylation events (i.e. Ser(P)-403/404 and Ser(P)-409/410),
p-T153/Y155 is not linked to the formation of aggregates in
FTLD. This is in agreement with our cell-based data suggesting
that p-T153/Y155 regulates TDP-43 function and localization
and that it is linked to soluble protein under conditions that
promote TDP-43 misfolding (Fig. 4A). However, at this time,
we cannot exclude the possibility that increased p-T153/Y155
levels, or specific patterns of detection may be observed in dif-
ferent types of TDP-43 proteinopathies.
TDP-43 recruitment to stress granules (SGs) has been
observed upon exposure to oxidative and proteotoxic stress
(11). To investigate whether phosphorylationmediates recruit-
ment of TDP-43 to SGs upon heat shock, we analyzed the colo-
calization of p-T153/Y155with the SGmarkerT-cell-restricted
intracellular antigen-related protein (TIAR). TIAR-positive
SGs formed in the cytoplasm following heat shock (Fig. 4C).
However, we did not observe recruitment of p-T153/Y155 or
FIGURE 2.Antibodyp-T153/Y155-TDP-43 specifically detects heat shock-
mediated TDP-43 phosphorylation. A, immunoblots of HeLa cells treated
with TDP-43-specific and control siRNA to compare levels of p-T153/Y155-
TDP-43 following heat shock stress. Error bars, S.D. n 4. B, detection of the
heat shock-associated signal in SH-SY5Y cell lysate with p-T153/Y155-TDP-43
antibody blocked with a TDP-43 peptide corresponding to the Thr-153/Tyr-
155 region (amino acids 148–161) phosphorylated at Thr-153 and Tyr-155
(T153P/Y155P), or with the corresponding non-phosphorylated peptide, as
control. Two concentrations of peptides were used low (L) and high (H),
described under “Experimental Procedures.” C, p-T153/Y155-TDP-43 detec-
tion of control and -phosphatase-treated lysates from control and heat
shock-treated SH-SY5Y cells.
FIGURE 3. p-T153/Y155-TDP-43 detects nucleolar localization of TDP-43
in the dense coil-like structures. A, fluorescence imaging of non-treated
HeLa cells showing total TDP-43 and p-T153/Y155-TDP-43 localization. B,
p-T153/Y155 colocalization with the nucleolar marker fibrillarin in HeLa and
SH-SY5Y cells as seen by confocal microscopy. C, detection of p-T153/Y155 in
HeLa cells upon heat shock comparedwith control-treated cells. Bars, 10m.
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phospho-independent TDP-43 to SGs, in agreement with pre-
vious reports (27). In summary, our findings indicate that phos-
phorylation at Thr-153/Tyr-155 is not linked to aggregation or
stress granule recruitment of TDP-43. Instead, we find that in
conditions that trigger TDP-43 misfolding, such as heat shock,
p-T153/Y155 is associated with a soluble conformation of the
protein. However, at this time, we cannot exclude the possibil-
ity that increased TDP-43 aggregation leads to structures that
make the Thr-153/Tyr-155 inaccessible to phosphorylation.
Next, we asked whether increased TDP-43 phosphorylation
during HSR occurs upon activation of two pathways that medi-
ate TDP-43 clearance: the ubiquitin proteasome system (UPS)
and macroautophagy (autophagy) (28–30). Cells treated with
the UPS inhibitor MG132, which induces the accumulation of
TDP-43 destined for UPS degradation (28), did not show
changes p-T153/Y155 levels (Fig. 4B). Immunofluorescence
analysis showed the accumulation of cytoplasmic aggregates of
total TDP-43 following MG132 treatment (Fig. 4D), as previ-
ously shown (29). However, we observed no colocalization of
p-T153/Y155 with these aggregates. We then asked whether
p-T153/Y155 mediates autophagy-associated degradation of
TDP-43. Cells were exposed to conditions that either increase
autophagy (trehalose, serum starvation), or prevent autophago-
some-lysosome fusion (thapsigargin). The levels of p-T153/
Y155 were unaffected under these conditions (Fig. 4B). More-
over, we observed no colocalization of p-T153/Y155 with
microtubule-associated protein light chain 3 (LC-3), a marker
of autophagy vesicles (Fig. 4E). These results indicate that phos-
phorylation at Thr-153/Tyr-155 is not linked to known path-
ways of TDP-43 clearance.
MEK Regulates TDP-43 Phosphorylation at Thr-153/
Tyr-155—The dual specificity mitogen-activated protein/ERK
kinase (MEK) (isoforms 1/2, MAP2K1/2) is a prime candidate
to phosphorylate at Thr-153/Tyr-155 based on prediction anal-
ysis of consensus sequence. Amino acid sequence alignment of
the Thr-153/Tyr-155 region with the dual phosphorylation site
of the well established MEK substrates ERK1/2 (extracellular
signal-regulated kinase) is shown in Fig. 5A. The phosphoryla-
tion sites show conservation of the TEY motif, which is unique
for MEK substrates compared with dual phosphorylation con-
sensus sequences of other kinases in the MAPK family. The
glutamic acid residue in themotif is critical for efficient ERK1/2
phosphorylation by MEK (31). Heat shock treatment dramati-
cally increased activation and phosphorylation of MEK (Fig.
5B), inagreementwithpreviousresults(32).Thistriggeredphos-
phorylation and activation of ERK as well as phosphorylation of
a downstream substrate MSK1 (Fig. 5B). We investigatedMEK
phosphorylation of TDP-43 by use of specific kinase inhibitors,
PD184352 and PD98059. Inhibitor treatment prior to heat
shock blocked Thr-153/Tyr-155 phosphorylation (Fig. 5C).
However, inhibition of the downstream kinase ERK with
FR180204 did not decrease Thr-153/Tyr-155 phosphorylation
(Fig. 5C). Addition of okadaic acid, which blocks MEK inacti-
vation by inhibiting protein phosphatase PP1/2A, increased
p-T153/Y155 levels under control and heat shock conditions
(Fig. 5D). This effect was blocked by addition of theMEK inhib-
itor PD184352. Furthermore, overexpression of a constitutively
active mutant of MEK1, GFP-MEK1_DD (S218D/S222D),
robustly increased TDP-43 phosphorylation at Thr-153/Tyr-
155 in non-treated cells (Fig. 5E). We also observed increased
FIGURE 4. p-T153/Y155 is not associated with aggregation, stress granule recruitment, or clearance of TDP-43. A, fractionation of SH-SY5Y cells per-
formedwith control, heat shock-treatedcells (43 °C for 30min), andcells allowed to recover at 37 °C for 1or 2h (1hr R,2hr R) followingheat shock. Immunoblots
of the total lysate (CL), RIPA (R), and urea (U) soluble fractions detecting p-T153/Y155 and total TDP-43. Equal volumes of total lysate and RIPA soluble fraction
were loaded,whereas the urea fraction is 5-foldmore concentrated. B, immunoblots of SH-SY5Y cells treatedwith theUPS inhibitorMG132 (20M for 5 h), heat
shock (HS: 43 °C for 30 min), trehalose (100 mM for 24 h), thapsigargin (THP: 1 M, 2 h), and serum starvation (24 h). C, fluorescence microscopy of control and
heat shock-treated HeLa cells detecting p-T153/Y155 and a stress granule marker, TIAR. Arrows indicate TIAR-positive stress granules. D, control and MG132-
treated HeLa cells (20 M,5 h). Arrows indicate TDP-43 cytoplasmic aggregates detected with a phospho-independent antibody. Bars, 10 m. E, control and
trehalose (100 mM, 24 h) treated HeLa cells. Formation of autophagy vesicles (arrow, lower panels) visualized upon transfection with GFP-fused microtubule-
associated protein 1A/1B-light chain 3 (LC3). Bars, 25 m.
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phosphorylation of a hemagglutinin (HA)-tagged TDP-43
expressed in the presence of the constitutively active MEK
compared with control (supplemental Fig. S6). Collectively,
these findings strongly suggest that TDP-43 is a novel sub-
strate of MEK and that heat shock is not a prerequisite for
Thr-153/Tyr-155 phosphorylation by constitutively active
MEK.
MEK Phosphorylation at Thr-153 and Tyr-155 Reduces
TDP-43 regulation of Splicing—To explore the effect of Thr-
153/Tyr-155 phosphorylation on TDP-43 function, we used a
reporter of splicing in cells. The well established cystic fibrosis
transmembrane conductance regulator (CFTR) exon 9 mini-
gene reporter (6, 33) was used in combination with a Thr-153/
Tyr-155 phosphomimetic TDP-43 variant (T153E/Y155E).
TDP-43 prevents exon 9 splicing through binding to a GU-rich
sequence upstream of the 3 splice site (Fig. 6A) (34). Direct
binding of TDP-43 to this sequence recruits additional
hnRNPs, in particular hnRNPA2, preventing recognition of the
3 splice site by steric hindrance (6). Under control conditions,
exon 9 showed 26% inclusion and, as expected, siRNA-
mediated knockdown of TDP-43 greatly increased exon inclu-
sion (supplemental Fig. S7A) (30). Splicing inhibition was re-
established upon expression of siRNA-resistant wild-type
TDP-43 (WTsiRes) (6, 33). The double mutant Phe-147 and
Phe-149 to Leu (F147L/P149L)was used as control in our assays
because of its inability to regulate splicing due to greatly
reduced RNA binding (35, 36). As expected, F147L/F149L
showed 50% loss in activity compared with wild-type (Fig.
6B). We found that the phosphomimetic T153E/Y155E substi-
tutions caused a 30% loss in splicing inhibition compared with
wild-type and T153E/Y155A, where the phosphosites were
mutated to alanine to prevent phosphorylation (Fig. 6B). Simi-
lar assays were carried out to further analyze the effect of
Thr-153/Tyr-155 and MEK regulation on TDP-43 activity.
Fig. 6C shows CFTR exon 9 splicing activity of control and
siRNA-treated cells as a function of MEK_DD expression. The
relative TDP-43 activity shown in Fig. 6C is a measure of CFTR
exon 9 inclusion levels in each condition compared with
WTsiRes cells. In control cells, MEK_DD reduced inhibition of
CFTR exon 9 splicing by 30% and this effect was lost upon
TDP-43knockdown.These results suggest thatMEK_DDphos-
phorylation of endogenous TDP-43 decreases splicing regula-
tory activity, as seen with the phosphomimetic mutation (Fig.
6B). Accordingly, the effect ofMEK_DDexpression on reporter
exon splicing was re-established in the presence of WTsiRes
TDP-43, where MEK_DD reduced splicing regulation by
50%. In contrast, this effect of MEK_DD was significantly
diminished upon expression of the siRes, non-phosphorylat-
able, T153A/Y155ATDP-43mutant. Collectively, our observa-
tions suggest that MEK phosphorylation at Thr-153/Tyr-155
inhibits the TDP-43-mediated regulation of splicing.
To elucidate whether the reduced splicing regulatory activity
seen with T153E/Y155E may be caused by changes in RNA
binding affinity, we generated recombinant TDP-43 using
a bacterial expression system. We expressed and purified
TDP-43 fused to aHis-SUMO tag at theN terminus to improve
yield and protein solubility. Next, we developed a fluorescence-
based RNA binding assay to measure the apparent dissociation
constant (Kd(app)) of TDP-43-RNA interactions as an alterna-
tive to the electromobility shift assay (EMSA). This new
method was based on our observations that the intrinsic fluo-
rescence of TDP-43 dramatically decreases upon RNA binding
FIGURE 5. TDP-43 is specifically phosphorylated by MEK at Thr-153/Tyr-155. A, human TDP-43 amino acid sequence surrounding Thr-153 and Tyr-155
(underlined) aligned with the human ERK1 activation loop sequence where MEK phosphorylates at Thr-202 and Tyr-204 (underlined). B, immunoblots of heat
shock and control treated HEK-293 and SH-SY5Y cells. The levels of phospho-independent proteins are shown and tubulin was used as loading control. C,
SH-SY5Y cells treated with specific MEK inhibitors PD184352 (10 M) and PD98059 (50 M), and with a specific inhibitor of the downstream kinase ERK
FR180204 (30 M). Cells were exposed to heat shock following 1 h of inhibitor treatment. D, SH-SY5Y cells treated with the protein phosphatase PP1/2A
inhibitor, okadaic acid (0.5 M), combined with the MEK inhibitor PD184352 for 1 h before heat shock. E, p-T153/Y155 levels analyzed upon expression of the
constitutively active GFP-MEK_DDmutant and a GFP control construct in SH-SY5Y cells in the absence of heat shock.
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(approximately 50%). Using this assay we obtained Kd(app) 
2.3 0.7 nM forwild-typeTDP-43 binding toA(GU)6with a 1:1
stoichiometry (Fig. 7A, Table 1), in close agreement with values
obtained by EMSA (37). As expected,mutations of Phe-147 and
Phe-149 (F147L/P149L), previously shown to make direct con-
tacts with GU repeats (35, 36), showed a great reduction in
binding affinity (Table 1). We investigated the contribution of
tryptophan residues to the changes in TDP-43 intrinsic fluores-
cence associated with RNA binding to further validate our
assays. Removal of the C-terminal (C) or both N- and C-ter-
minal domains (fragment 102–269) did not significantly alter
affinity or decrease the change in fluorescence compared with
full-length TDP-43 (Table 1). These results indicate that Trp
residues in the N and C terminus did not contribute to the
fluorescence change linked toRNAbinding.Moreover, they are
in agreement with previous work showing that the carboxyl-
and amino-terminal domains of TDP-43 do not contribute to
RNA binding (35). We then substituted the remaining trypto-
phans at positions 113 and 172, found in RRM1. Substitution of
Trp-113 to Ala (W113A) results in the loss of the fluorescence
signal change as a function of RNA, whereas W113F reduced
the fluorescence change by 50%, but had a modest effect on the
Kd(app) (Table 1). Mutations of Trp-172 to either phenylalanine
or alanine did not affect binding affinity or fluorescence change
in our assays (Table 1). Our findings strongly suggest that
FIGURE 6. Phosphomimetic substitutions at Thr-153/Tyr-155 modulate
TDP-43 activity. A, schematic representation of the CFTR exon 9 mini-gene
cellular reporter of TDP-43 activity. Exons and intron regions are represented
as boxes and lines, respectively. TDP-43 binding to UG repeats (UG13) near the
3 splice site inhibits exon 9 inclusion. The twomajor products of splicing are
shown to the right. B, RNAi-resistant (siRes) TDP-43 mutants were expressed
in siRNA-treated HeLa cells. Relative TDP-43 activity was calculated compar-
ing wild-type siRes. The effect of the RNA binding-deficient mutant, F147L/
F149L, was used as control. Error bars, S.D., n  5. C, constitutively active
MEK_DD, or control GFP vector, expressed in siRNA or control treated cells.
Reporter activity was analyzed relative to siRes wild-type (WTsiR). Values rep-
resent the averages of independent transfection experiments. Error bars, S.D.,
n 4.
FIGURE 7. Fluorescence-based assay to measure TDP-43 RNA binding
affinity for GU-repeats. A, intrinsic fluorescence (F) of recombinant TDP-43
upon titration of A(UG)6 RNA normalized by the fluorescence in the absence
of RNA (F0). Shownare F/F0 values at fourdifferent TDP-43 concentrations and
data were analyzed according to Equations 1 and 2 under “Experimental Pro-
cedures.” The best fit values for the apparent equilibrium dissociation con-
stant, Kd(app), are shown in Table 1. B, schematic representation of full-length
TDP-43 highlighting Trp-113 and Trp-172 in RRM1. Lower panel shows the
surface and ribbon representationof the102–269 fragmentbound toGU-rich
RNA (36). Tryptophan residues in RRM1 are highlighted inmagenta.
TABLE 1
Binding affinities of wild-type andmutant TDP-43
The apparent equilibrium dissociation constant Kd(app) measured for recombinant




C (aa 1–261) 2.8 0.6









Novel TDP-43 Phosphorylation Is Heat Shock-induced viaMEK













changes surrounding the Trp-113 region are principally
responsible for the observed decrease in intrinsic fluorescence
upon RNA binding. Trp-113 makes sequence-specific contacts
with GU-rich RNA and substitutions of this residue reduce
binding affinity (36, 37). These interactions, according to our
data, result in dramatic changes in intrinsic fluorescence that
may be exploited to accurately measure RNA binding affinity.
Analysis of T153E/Y155E using the fluorescence-based assay
showed a 5-fold decrease inA(GU)6 binding affinity in the pres-
ence of the phosphomimetic substitutions comparedwithwild-
type, whereas the corresponding alanine mutations did not
affect binding (Table 1). These results are consistent with the
reduced splicing regulatory function seen in the presence of the
phosphomimetic substitutions and strongly suggest that phos-
phorylation modulates TDP-43 activity.
Discussion
TDP-43 regulates hundreds of genes through different RNA
processingmechanisms, in particular through the regulation of
splicing (18, 19, 22). TDP-43 cellular localization is highly
dynamic anddefects in nuclear import are linked to aggregation
and neurotoxicity (9, 38, 39). How these various TDP-43 func-
tions are controlled in cells is largely unknown. Previously
determined TDP-43 phosphorylation sites at Ser-403/404 and
Ser-409/410 are poorly associated with the control of TDP-43
function and aremostlymarkers of pathological aggregates (25,
26). Here we report dual phosphorylation of TDP-43 at Thr-
153/Tyr-155 and provide strong evidence that it is specifically
controlled by the MAPK/ERK kinase MEK. This phosphoryla-
tion is dramatically up-regulated by the HSR in human cells.
The increase in p-T153/Y155 is not associated with greater
aggregation or protein clearance under the conditions tested.
We find, instead, that p-T153/Y155 remains soluble under con-
ditions that promote TDP-43 misfolding. In support of a func-
tional role of p-T153/Y155, our results show that increased
MEK activity significantly alters TDP-43-mediated control of
exon splicing in cells.Our observations suggest that the effect of
MEK is mediated by phosphorylation at Thr-153/Tyr-155. The
decrease in TDP-43 activity may be at least partly explained by
a reduction in RNAbinding as we find that T153E/Y155E binds
GU-rich RNA with 5-fold lower affinity. Future studies should
determine whether phosphorylation changes RNA sequence
specificity, or whether it affects protein interactions required
for TDP-43 regulation of splicing, such as binding to hnRNPA2
(6).
The dramatic up-regulation of TDP-43 phosphorylation by
heat shock, along with recent findings on the reduction of
TDP-43 aggregationuponheat shock factor 1 (HSF1) activation
(40, 41), point to a previously unappreciated role of HSR in
TDP-43 homeostasis and posttranslational regulation. In addi-
tion to hyperthermic stress, HSR is activated by other types of
insults that compromise protein homeostasis (42, 43), and
defects in this response are commonly found in human disease
including neurodegeneration. Therapies targeting HSR path-
ways, such as those showing promising effects in ALS (44),
may be designed to specifically target TDP-43. We posit that
p-T153/Y155 might mediate interactions with chaperones/
heat shock proteins that prevent TDP-43misfolding and aggre-
gation, such as DNAJB2a and Hsp70 (40). Alternatively, it may
be associated with anHSR-mediated clearance pathway, differ-
ent from UPS and autophagy, which prevents aggregate accu-
mulation. We also propose the alternative, tantalizing scenario
that TDP-43 might regulate the expression of the HSR target
genes whose levels are controlled by alternative splicing during
the proteotoxic stress response (45). Based on our findings, this
HSR-specific function of TDP-43 may be controlled by phos-
phorylation at Thr-153/Tyr-155.
MEK is activated upon heat shock and was recently shown to
maintain protein homeostasis, at least in part, by phosphorylat-
ing and activating HSF1 (32). Previously, the only other recog-
nized MEK substrate was ERK. Now, we provide evidence that
TDP-43 is a novel MEK substrate in the presence and absence
of heat shock. MEK may not be the only kinase to phosphory-
late TDP-43 at Thr-153/Tyr-155, however, we observed no sig-
nificant reduction of HSR-induced p-T153/Y155 levels upon
specific inhibition of MAPK-related dual specificity kinases,
namely JNK and p38 kinase (supplemental Fig. S8). Our evi-
dence suggests that cellular processes associated with active
MEK, such as proliferation and differentiation, may also induce
p-T153/Y155 and regulateTDP-43 function. Based onour find-
ings that p-T153/Y155 is associated with TDP-43 solubility in
conditions that trigger protein misfolding, future work should
determine whether MEK activation prevents TDP-43 aggrega-
tion and blocks TDP-43-associated neurotoxicity.
Our findings showing the specific localization of phosphor-
ylated TDP-43 suggest that nucleolar TDP-43 recruitment is
regulated by phosphorylation andmay provide new insight into
a previously unrecognized role of TDP-43 in cellular func-
tion linked to nucleolar RNA processing. In the C9ORF72
hexanucleotide repeat expansion, which is the most common
cause of familial ALS and FTD (46, 47), the nucleolar compart-
ment is disrupted by the generation of arginine-rich (GR and
PR) dipeptide repeats (48–50). GR and PR are toxic, accumu-
late in nucleoli, and bind to proteins containing low complexity
sequence domains including TDP-43 (51, 52). These findings
strongly suggest that one of the principal pathogenic mecha-
nisms in ALS/FTD is abnormal nucleolar function. Future
experiments will determine TDP-43 function, particularly the
role of p-T513/Y155 in nucleolar-specific RNA processing, and
the effect of Arg-rich dipeptide repeats on this function. This
may elucidate a convergent process resulting fromTDP-43 and
C9ORF72-associated dysfunction in ALS/FTD pathogenesis.
Experimental Procedures
Materials—All reagents are from Sigma unless otherwise
specified. The human cell lines: neuroblastoma SH-SY5Y, epi-
thelial HeLa, and embryonic kidney HEK-293 cells were pur-
chased from ATCC.
Plasmid Construction—FLAG-tagged wild-type TDP-43,
siRNA-resistant construct for mammalian expression was pre-
viously described (7). This served as template for site-directed
mutagenesis using the QuikChange site-directed mutagenesis
kit (Agilent Technologies) to generate TDP-43 mutants for
mammalian expression. MEK1_DD-GFP (S218D/S222D) was
generated by site-directed mutagenesis using the wild-type
MEK1-GFP construct (Addgene, 14746) as template. pEGFP-
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LC3 vector was purchased from Addgene (24920). Constructs
for bacterial TDP-43 expression (SUMO-TDP43) were made
by cloning TDP-43 in pET-28b/His-SUMO (53) using pQTD-
PBam_FW and SacTDPend_RV. This construct was the tem-
plate to generate TDP-43 mutants for bacterial expression
through site-directed mutagenesis as above. pQTDPBam_FW
and Sac_269_RV; Bam_102_FW and Sac_269_RV were used to
clone C-TDP-43 and fragment 102–269, respectively. Oligo-
nucleotides used for mutagenesis and cloning are described in
supplemental Table S1. The pLKO vector for TDP-43 down-
regulationwas generated by ligation of shT2_FWand shT2_RV
annealing product into pLKO.1-puro vector digested with AgeI
and EcoRI.
Cell Culture, Fractionation, and Splicing Assays—Human
cell lines were grown in growth media, Dulbecco’s modified
Eagle’s medium, 4,500 mg/liter of glucose, L-glutamine, and
sodium bicarbonate, and supplemented with filtered fetal
bovine serumat 10%. For the soluble and insoluble fractions cell
pellets were resuspended in RIPA buffer (150 mMNaCl, 50 mM
Tris, pH 8.0, 1% Nonidet P-40, 5 mM EDTA, 0.5% sodium
deoxycholate, 0.1% SDS, 1 protease inhibitor mixture, 1
Phostop Phosphatase inhibitor mixture (Roche Applied Sci-
ence)). Lysates were sonicated using a Bioruptor Pico (Diag-
enode) using 10, 30-s on/30-s off, cycles at 4 °C and centrifuged
at 40,000 g for 30min at 4 °C. The pellet was rinsedwithRIPA
buffer and the final pellet was resuspended in urea buffer (7 M
urea, 2 M thiourea, 4% CHAPS, and 30 mM Tris, pH 8.5). Stable
HEK-293 cells expressing HA-tagged TDP-43 under tetracy-
cline induction (7) were used for immunoprecipitation experi-
ments as previously described (54). RNAi-mediated down-reg-
ulation of TDP-43 was carried out as previously described (33)
and siCONTROL Nontargetting siRNA#1 (Dharmacon) was
used as control. shRNA-mediated down-regulation of TDP-43
was carried out by generating lentiviral particles in HEK-293T
cells using a pLKO vector system (pCMV8.2R, pCMV-
VSV-G, generous gifts of Susana Gonzalo’s lab, St. Louis Uni-
versity). shRNA luciferase lentiviral particles were generated
for control transduction. HEK-293T cells were transfected
with Lipofectamine 2000 (Life Technologies) in Opti-MEM
Reduced Serum Media (Life Technologies) according to man-
ufacturer’s protocols. After 6 h, media was replaced with
growth media and cells were incubated at 37 °C, 5%CO2 for 48 h.
After 48 h, the lentivirus-containingmediawas collected and filter
sterilized with a 0.45-m filter. HeLa cells were transduced with
control and TDP-43-shRNA lentiviral particles with Polybrene
transfection reagent. TDP-43 knockdown clones were generated
bypuromycin selection (1g/ml) 48h after transduction.TDP-43
down-regulation was confirmed by immunoblotting.
Splicing assays were carried out in HeLa cells transiently
transfectedwith Lipofectamine 2000 andOligofectamine in the
case of siRNA (Life Technologies) according to themanufactu-
rer’s protocols. Assays were performed using the CFTR
reporter mini-gene as previously described (6, 33). Briefly, fol-
lowing two transfections with control or siRNA TDP-43 (0.1
nmol) in a 6-well format, cells were co-transfected with FLAG-
TDP43 siRNA-resistant constructs of wild-type or mutant
TDP-43 and the CFTR reporter (0.3 g each) (17). RNA was
extracted after 24 h and RT-PCR analysis was performed to
compare the levels of exon inclusion/exclusion. PCR products
were quantified with ImageJ.
Phosphatase Treatment—Cell lysates containing 30 g of
total protein were incubated with 400 units of -protein phos-
phatase (New England Biolabs) for 1 h at 37 °C according to the
manufacturer’s instructions.
Peptide Competition—p-T153/Y155 antibody was incubated
with a peptide corresponding to amino acids 148–161 of
TDP-43 phosphorylated at positions Thr-153 and/or Tyr-155.
Non-phosphorylated peptide was used as a control. Prior to
immunoblotting or immunofluorescence 1 mg/ml of p-T153/
Y155-TDP-43 antibody was incubated with 0.02 g/ml (low)
and 1 g/ml (high) peptide for 1 h at 25 °C.
Immunoblotting and Immunofluorescence Microscopy—Cell
pellets were resuspended in lysis buffer (0.25 M NaCl, 15 mM
Hepes, pH 7.5, 0.5% Nonidet P-40, 10% glycerol, 1 protease
inhibitor mixture, 1 Phostop Phosphatase inhibitor mixture
(RocheApplied Science)). Approximately 30g of total protein
were loaded for immunoblot analyses, unless otherwise speci-
fied. Samples were measured by Bradford assays. Proteins were
separated by SDS-PAGE and transferred to nitrocellulose (0.22
m, GE Healthcare). Membranes were blocked with 5%
BSA/TBS-Tween and immunodetection was carried out by
enhanced chemiluminescence (ECL, Pierce, ThermoFisher Sci-
entific). Antibodies against phospho-independent TDP-43
were used to compare p-T153/Y155 levels with total TDP-43.
Either tubulin or GAPDH was used as the loading control.
Indirect immunofluorescence was carried out as previously
described (17). Cells were observed on a Leica DM5000B
microscope equippedwith theDFC350FXdigital camera (Leica
Microsystems Inc.). A 63/1.4 oil immersion objective was
used for confocal microscopy studies on a TCS SP5microscope
(Leica) using the LAS AF software.
Immunohistochemistry—We studied FTLD cases with
TDP-43 pathology and age-matched controls from the North-
western Neuropathology Core Tissue Bank (NADCAG13854).
Frontal cortex and dentate gyrus sections were immunostained
according to previously described protocols (55) with p-T153/
Y155-TDP-43. pS409/410 (CosmoBioUSA) antibodywas used
as control.
Expression and Purification of Recombinant TDP-43—
Recombinant TDP-43 was expressed in BL21(DE3) Escherichia
coli cells from the SUMO-TDP43 plasmid. Induction was car-
ried out with 0.3 mM isopropyl -D-thiogalactopyranoside and
cells were grown at 25 °C for 4 h. Cell pellets were resuspended
in lysis buffer (500 mM NaCl, 50 mM Tris, pH 8.0, 1 mM Tris(2-
carboxyethyl)phosphine, 10% sucrose, 10% glycerol, 5 mM
CHAPS, 0.1% sodium deoxycholate, EDTA-free protease
inhibitormixture, 2.5g/ml of lysozyme, 10g/ml of DNase I).
Lysates were centrifuged for 20 min at 20,000  g at 4 °C fol-
lowing sonication on ice. Protein was isolated on nickel-
nitrilotriacetic acid resin (McLab) by affinity chromatography
(AKTA-Start, GE Healthcare). The column was washed with
Buffer A: 500 mM NaCl, 50 mM Tris, pH 8.0, 10% sucrose, 10%
glycerol, 50 mM imidazole. Recombinant TDP-43 was eluted
with Buffer A and 300 mM imidazole. The SUMO tag was
removed with Ulp1 protease at a 1:1,000 (w/w) ratio as
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described (53). Ulp1 was generously provided by Sergey
Korolev’s group. All steps were carried out at 4 °C.
Fluorescence Titration RNA Binding Assays—TDP-43 intrin-
sic fluorescence was measured upon titration with increasing
concentrations of A(GU)6 RNA on a Fluoromax-4 spectrofluo-
rometer (Horiba Scientific). Fluorescence readings were per-
formed in a 1-ml cuvette at four different recombinant TDP-43
concentrations in the range of 10–100 nM in the presence of
200mMNaCl, 20mMTris, pH 8.0, 0.1% PEG-8000, 2% glycerol,
at 25 °C. Protein was excited at 280 nm (slits 5/10, exposure
time of 0.02 s), and emission was recorded at 340 nm. We
observedno significant photobleaching under these conditions.
Data were analyzed with Origin (version 8.1, OriginLab)
according to Equation 1,
F  F0  Fmax (Eq. 1)
where F is fluorescence, F0 is F in the absence of RNA, Fmax is
the total change in F at saturation.
 
Kd	app





Equation 2 describes the fractional saturation in terms of the
apparent equilibrium dissociation constant Kd(app), the total
concentration of TDP-43 (Tt), total RNA concentration (Rt),
and TDP-43:RNA binding stoichiometry, N. Four TDP-43-
RNA binding curves were analyzed simultaneously to obtain
Kd(app) and N.
Antibodies—Immunoblots and indirect immunofluores-
cence were performed with: rabbit polyclonal and mouse
monoclonal anti-TDP-43 (ProteinTech 10782-2-AP, Abcam,
ab109535), anti-TIAR (BDBiosciences, 610352), anti-fibrillarin
(Abcam, ab4566), mouse anti-tubulin (Andres Muro, Trieste,
Italy), anti-GAPDH (Abcam, ab181602), anti-MEK (Abcam,
ab178876), anti-phospho-MEK1/2 (Cell Signaling, number
9154), anti-ERK1/2 (Cell Signaling, number 4695), anti-phos-
pho-ERK1/2 (Cell Signaling, number 4370), anti-MSK1 (Cell
Signaling, number 3489), and anti-phospho-MSK1 (Cell Sig-
naling, number 9595). The rabbit polyclonal antibodies recog-
nizing p-T153/Y155 and p-Y155-TDP-43 were produced by
21st Century Biochemicals, MA. Peptide including TDP-43
amino acids 148–161 phosphorylated at either Thr-153/Tyr-
155 orTyr-155 served as epitope for antibody production.Anti-
body specificity was enhanced by affinity purification to select
for binding to phosphorylated Thr-153/Tyr-155 or Tyr-155,
but not the corresponding non-phosphorylated peptides.
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